YOSEF REFAELI, PH.D.
Chief Executive Officer, Co-Founder
Dr. Refaeli is Associate Professor, Charles C. Gates Program in Regenerative Medicine and Stem Cell Biology, Department of Dermatology, University of Colorado Denver School of Medicine. He received his Ph.D. from Harvard University and his A.B. degree from the University of Pennsylvania.
BRIAN TURNER, PH.D., M.H.S.
President and Chief Scientific Officer, Co-Founder
Dr. Turner received his Ph.D. from the University of Colorado Health Sciences Center, holds a Masters in Public Health from the Johns Hopkins School of Public Health and received his A.B. degree in History from Cornell University. Dr. Turner is also a Research Instructor at the Charles C. Gates Program in Regenerative Medicine and Stem Cell Biology, Department of Dermatology, University of Colorado Denver School of Medicine.
JAMES KELLY, B.A.
Chief Financial Officer
Mr. Kelly began his career as an investment banker and worked for Deutschebank Securities and Robertson Stephens & Company. Following his banking career, he worked at a number of start-ups and served as the Global Head of Business Development for Intellectual Ventures. He has lived and worked in Japan for over 30 years and received his B.A from Colgate University.
ROBERT D. GULOCK, B.A.
Chief Commercial Officer
Mr. Gulock is a sales, marketing, and regulatory strategist with a strong track record in international business development, new product development, operations, and performance improvement. He has worked for Sonova, Advanced Bionics, Boston Scientific and Johnson & Johnson. Mr. Gulock’s education includes a B.A. in Public Administration-Finance from the University of Michigan.